New information has been released regarding the suspension of former Strikeforce light heavyweight champion Rafael ‘Feijao’ Cavalcante and the positive drug test stemming from his May 19 bout against Mike Kyle.
According to a release from the California State Athletic Commission (CSAC), the Brazilian fighter tested positive for stanozolol metabolites.
The resulting test earned Cavalcante a one-year suspension retroactive to the date before his fight, May 18, 2012, and his fight with Kyle has been overturned and ruled a no-decision.
“Our primary concern is for the health and safety of fighters,” said CSAC Executive Officer George Dodd. “Anabolic agents and other banned substances put not only the users of those agents at risk, but their opponents as well. The commission simply will not tolerate their use.”
The test that Cavalcante underwent was tested by the World Anti-Doping Agency facility at UCLA in Los Angeles.
Cavalcante also received a $2500 fine for the infraction, and does have the right to appeal the suspension of his license.
The drug stanozolol has been one of the most frequently used anabolic steroids found in many pro athletes over the years, including several prominent MMA fighters.
UFC middleweight Chris Leben, former UFC heavyweight champion Tim Sylvia and former Strikeforce women’s champion Cris ‘Cyborg’ Santos are just a few of the names that litter the list of fighters suspended for similar infractions with this type of steroid.
According to sources, Feijao and his management team do plan on appealing the suspension he’s facing from the commission.